During the phase 2 trials, researchers monitored injection-site tolerability closely to ensure that local reactions did not undermine patient adherence or signal broader immune-related problems
Liver enzymes, lipid panels, and PSA (prostate-specific antigen) complete a standard safety monitoring picture
Additionally, data on GLP-1 RA use in this population is sparse
At this stage, healthy eating habits may start to feel easier to maintain
In early research, Retatrutide has shown some of the strongest weight-loss results to date, along with improvements in blood sugar, liver fat, and overall metabolic health
Furthermore, no food, beverage or other medication can be consumed for another half hour